Comments
Loading...

Halozyme Therapeutics

HALONASDAQ
Logo brought to you by Benzinga Data
$56.42
0.591.06%
At close: -
$56.42
0.000.00%
After Hours: 4:00 PM EDT
62.5%
Overview Rating
Good
Technicals Analysis
100
0100
Financials Analysis
40
0100

Halozyme Therapeutics (NASDAQ:HALO) Stock Quotes, Forecast and News Summary

Halozyme Therapeutics Stock (NASDAQ: HALO) stock price, news, charts, stock research, profile.

40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
2
1
Oct 24
3
1
Nov 24
2
Dec 24
1
2
Jan
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.2
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$56.30
Close$56.42
Volume / Avg.1.06M / 1.68M
Day Range$56.06 - $57.46
52 Wk Range33.15 - 65.53
Market Cap$7.18B
P/E Ratio18.49
Dividend Yield-
ExchangeNASDAQ
RSI
69
Short Interest-
Days to Cover5.35

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
HALO

FAQ

Q

How do I buy Halozyme Therapeutics (HALO) stock?

A

You can purchase shares of Halozyme Therapeutics (NASDAQ:HALO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Halozyme Therapeutics (HALO) competitors?

A

There are no as such competitors for Halozyme Therapeutics.

Q

What is the forecast, or price target, for Halozyme Therapeutics (HALO) stock?

A

Halozyme Therapeutics has a consensus price target of $58.17.

Q

What is the current price for Halozyme Therapeutics (HALO)?

A

The stock price for Halozyme Therapeutics (NASDAQ: HALO) is $56.42 last updated January 30, 2025 at 4:00 PM EST.

Q

Does Halozyme Therapeutics (HALO) pay a dividend?

A

There are no upcoming dividends for Halozyme Therapeutics.

Q

When is Halozyme Therapeutics (NASDAQ:HALO) reporting earnings?

A

Halozyme Therapeutics’s Q4 earnings are confirmed for Tuesday, February 18, 2025.

Q

Is Halozyme Therapeutics (HALO) going to split?

A

There is no upcoming split for Halozyme Therapeutics.

Q

What sector and industry does Halozyme Therapeutics (HALO) operate in?

A

Halozyme Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.